| |
Acne scarring
This article on Acne scarring was found at Westside Dermatology Group as a PDF file. What I have tryed to do is put it into a web page form.
This is a technical kind of an article that I think is worth reading through. When you do talk to your Doctor about your Acne scarring you will have a good idea what the Doc is saying.
The whole article is 17 pages and I hope that you fin it easer to read this way. the PDF file can be found hear
Acne scar treatments
Look for the Downloadable Resources on the bottom left of the page.
A review and current treatment modalities
By Albert E. Rivera, DO
Kirksville, Missouri
Acne is a prevalent condition in society and often results in secondary
damage in the form of scarring. Of course, prevention is the optimal
method to avoid having to correct the physically or emotionally
troublesome scars. However, even with the best efforts, scars will certainly
arise. This article attempts to give a broad overview of multiple management
options, whether medically, surgically, or procedurally
based. The hope is that a general knowledge of the current
available alternatives will be of value to the physician when confronted
with the difficult task of developing a treatment plan for acne-scarred
individuals, even in challenging cases. ( J Am Acad Dermatol 2008;59:659-76.)
|
Abbreviations used in this article :
Er:YAG: erbium:yttrium-aluminum-garnet
FDA: Food and Drug Administration
HA: hyaluronic acid
IPL: intense pulsed light (not listed)
Nd:YAG: neodymium:yttrium-aluminum-garnet
PDL: pulsed dye laser
TCA: trichloroacetic acid
|
ACNE
Acne is caused and characterized by multiple factors, including:
Propionibacterium acnes activity; increased sebum production; androgenic
stimulation; follicular hypercornification; lymphocyte, macrophage,
and neutrophil inflammatory response; and cytokine activation.
Multiple surveys and studies have attempted to determine the prevalence of
acne within various groups. None of these are without shortcoming but all
have done well with targeted, representative groups. A good review, too
extensive to be included in this work, containing tables (consisting of
15 general population or schoolchildren-based cross-sectional surveys along
with 3 separate case-control studies) and discussions of several of these
publications has been compiled and published by a group of Australian
authors.
In 1978, the most comprehensive study to date,
HANES-1,
Established the prevalence of acne vulgaris
within 20,749 US citizens aged 1 to 74 years
(excluding those hospitalized for another dermatologic
condition and those with the disease in remission)
to be 68 per 1000 for both sexes, 70.4 per 1000
for men and boys and 65.8 per 1000 for women and
girls. Cystic acne was present in 1.9 per 1000 for both
sexes, 3.3 per 1000 in men and boys and 0.6 per 1000
in women and girls. The common complication of
acne scarring was found in 1.7 per 1000 for both
sexes, 2.0 per 1000 in men and boys and 1.3 per 1000
in women and girls. Approximately 80% of girls and
90% of boys develop acne in their adolescent years.
The peak incidence for girls is age 14 to 17 years and
age 16 to 19 years for boys and men. Furthermore, of
individuals aged 11 to 30 years, 80% have some
degree of active acne.
More recently, a community-based study, using
the Leeds grading technique for acne3 and including
749 patients, all older than 25 years (range 25-58
years, mean age 39.5 years), was used to determine
overall acne prevalence as 58% of women and 40%
of men. ‘‘Clinical’’ ([0.75 on the Leeds scale) acne
was present in 3% of men and 12% of women. The
prevalence of clinical acne decreased significantly
only after age 45 years. Their definition of scarring
was noted in 14% of the women and 11% of the men
in the study.4 However, even in the two examples
above, statistics are often inaccurate because most
estimations are based on patients who seek treatment,
physician diagnoses, hospital records, compensation
claims, medication purchases, or various
exclusion or inclusion criteria, rather than a full
cross-population sample.
From the Department of Dermatology, Northeast Regional Medical
Center.
Funding sources: None
.
Conflicts of interest: None declared.
Please see the Appendix for a listing of the manufacturers of
brand name drugs mentioned in this article.
Reprint requests: Albert E. Rivera, DO, Department of Dermatology,
Northeast Regional Medical Center, 700WJefferson St, Kirksville,
MO 63501. E-mail: bo_rivera@yahoo.com.
Published online July 28, 2008.
0190-9622/$34.00
ª 2008 by the American Academy of Dermatology, Inc.
doi:10.1016/j.jaad.2008.05.029
Next Page
Acne Scarring
|